Emerging Role of FAPI PET Imaging for the Assessment of Benign Bone and Joint Diseases

Positron emission tomography/computed tomography (PET/CT) is a hybrid imaging modality that has recently experienced a wide increase in its use and applications [...].

[1]  B. Gückel,et al.  [18F]Fluoride Positron-Emission Tomography (PET) and [18F]FDG PET for Assessment of Osteomyelitis of the Jaw in Comparison to Computed Tomography (CT) and Magnetic Resonance Imaging (MRI): A Prospective PET/CT and PET/MRI Pilot Study , 2022, Journal of clinical medicine.

[2]  P. Zola,et al.  Use of Positron Emission Tomography for Pregnancy-Associated Cancer Assessment: A Review , 2022, Journal of clinical medicine.

[3]  Angela C. Rieger,et al.  Non-oncologic incidental uptake on FAPI PET/CT imaging. , 2022, The British journal of radiology.

[4]  Jiahe Tian,et al.  18F-FDG and 68 Ga-FAPI PET/CT for the evaluation of periprosthetic joint infection and aseptic loosening in rabbit models , 2022, BMC Musculoskeletal Disorders.

[5]  Lin Wang,et al.  Preclinical evaluation and pilot clinical study of [18F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  Xiao Jiang,et al.  Physiological tracer distribution and benign lesion incidental uptake of Al18F-NOTA-FAPI-04 on PET/CT imaging , 2022, Nuclear medicine communications.

[7]  Wei Liu,et al.  Intense 68Ga-FAPI Uptake in a Patient With Myositis Ossificans: Mimicking Bone Malignancy. , 2022, Clinical nuclear medicine.

[8]  G. Schett,et al.  FAPI PET Opens a New Window to Understanding Immune-Mediated Inflammatory Diseases , 2022, The Journal of Nuclear Medicine.

[9]  F. Bertagna,et al.  Prognostic Role of Pre-Treatment Metabolic Parameters and Sarcopenia Derived by 2-[18F]-FDG PET/CT in Elderly Mantle Cell Lymphoma , 2022, Journal of clinical medicine.

[10]  G. Treglia,et al.  Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents? , 2022, Contrast media & molecular imaging.

[11]  R. Gatta,et al.  Comparison between Two Different Scanners for the Evaluation of the Role of 18F-FDG PET/CT Semiquantitative Parameters and Radiomics Features in the Prediction of Final Diagnosis of Thyroid Incidentalomas , 2022, Journal of clinical medicine.

[12]  E. Demirci,et al.  Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET , 2022, Biomedicines.

[13]  X. Yang,et al.  Increased 68Ga-FAPI Uptake in Facet Joint Osteoarthritis in a Patient With Esophageal Cancer. , 2022, Clinical nuclear medicine.

[14]  X. Yang,et al.  Bone Tuberculous Granulomatous Inflammation Mimicking Malignancy on 68Ga-FAPI PET/CT. , 2022, Clinical nuclear medicine.

[15]  O. Decaux,et al.  Diagnostic Value of 18F-FDG PET/CT vs. Chest-Abdomen-Pelvis CT Scan in Management of Patients with Fever of Unknown Origin, Inflammation of Unknown Origin or Episodic Fever of Unknown Origin: A Comparative Multicentre Prospective Study , 2022, Journal of clinical medicine.

[16]  I. Durieu,et al.  Inflammation of Unknown Origin: Evaluation and Prognosis of 57 Cases , 2021, Journal of clinical medicine.

[17]  E. Lopci.  Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [18F]FDG PET/CT in Metastatic Melanomas and Lung Cancer , 2021, Journal of clinical medicine.

[18]  R. Gatta,et al.  Role of 18F-FDG PET/CT Radiomics Features in the Differential Diagnosis of Solitary Pulmonary Nodules: Diagnostic Accuracy and Comparison between Two Different PET/CT Scanners , 2021, Journal of clinical medicine.

[19]  G. Treglia,et al.  Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review , 2021, International journal of molecular sciences.

[20]  P. Choyke,et al.  FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis? , 2021, Cancers.

[21]  C. Klein,et al.  Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy , 2021, Rheumatology.

[22]  Shaobo Yao,et al.  Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT , 2021, Annals of Nuclear Medicine.

[23]  E. Arslan,et al.  18F-FDG PET/CT and 68Ga-FAPI-4 PET/CT Findings of Bilateral Knee Osteoarthritis in a Patient With Uveal Malignant Melanoma. , 2021, Clinical nuclear medicine.

[24]  Haojun Chen,et al.  Increased 68Ga-FAPI Uptake in Ankylosing Spondylitis in a Patient With Rectal Cancer. , 2021, Clinical nuclear medicine.

[25]  A. Chiti,et al.  State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  X. Lan,et al.  Fibrous Dysplasia Mimicking Skeletal Metastasis on 68Ga-FAPI PET Imaging. , 2021, Clinical nuclear medicine.

[27]  X. Lan,et al.  Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  Fengchun Zhang,et al.  Inflammatory Arthritis Induced by Anti-Programmed Death-1 Shown in 68Ga-FAPI PET/CT in a Patient With Esophageal Carcinoma. , 2021, Clinical nuclear medicine.

[29]  Huayu Sun,et al.  68Ga-DOTA-FAPI-04 PET/CT in Erdheim-Chester Disease. , 2021, Clinical nuclear medicine.

[30]  P. Sharma,et al.  Fibroblast Activation Protein Inhibitor PET/CT: A Promising Molecular Imaging Tool. , 2020, Clinical nuclear medicine.

[31]  L. Cai,et al.  [68Ga]Ga-DOTA-FAPI-04 PET/CT imaging in a case of prostate cancer with shoulder arthritis , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[32]  S. Hyun,et al.  18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Treatment Response of Pulmonary Multidrug-Resistant Tuberculosis , 2018, Journal of clinical medicine.